The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for gentamicin and aminoglycosides in general remember these work on the bacterial ribosome and there's some congruency between mitochondrial ribosomes and bacterial ribosomes and with sustained inhibition that can cause toxicity particularly in the kidney and the tubular epithelial cells also in inner ear hair cells and some other places so having some drug free time seems to allow the organelles to recover at least that's the hypothesis
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.